(VIANEWS) – OKEANIS ECO TANKER (OET.OL), HAFNIA LIMITED (HAFNI.OL), NEOEN (NEOEN.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. OKEANIS ECO TANKER (OET.OL)
1384.1% sales growth and 28.08% return on equity
Okeanis Eco Tankers Corp., a shipping company, owns and operates tanker vessels worldwide. It operates a fleet of 14 tanker vessels comprising six modern Suezmax tankers and eight modern VLCC tankers focusing on the transportation of crude oil. The company was incorporated in 2018 and is based in Neo Faliro, Greece.
Earnings Per Share
As for profitability, OKEANIS ECO TANKER has a trailing twelve months EPS of kr41.06.
PE Ratio
OKEANIS ECO TANKER has a trailing twelve months price to earnings ratio of 8.46. Meaning, the purchaser of the share is investing kr8.46 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.08%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6.5%, now sitting on 403.85M for the twelve trailing months.
More news about OKEANIS ECO TANKER.
2. HAFNIA LIMITED (HAFNI.OL)
1150.7% sales growth and 34.78% return on equity
Hafnia Limited owns and operates oil product tankers in Bermuda. It operates through Long Range II, Long Range I, Medium Range (MR), Handy size, and Specialized segments. The company transports clean and dirty, refined oil products, vegetable oil, and easy chemicals to national and international oil companies, and chemical companies, as well as trading and utility companies; and owns and operates 200 vessels. It provides ship owning, ship-management, investment, management, corporate support, and agency office services. In addition, the company provides integrated shipping platform, including technical management, commercial and chartering services, pool management, and large-scale bunker desk services. Hafnia Limited is based in Hamilton, Bermuda.
Earnings Per Share
As for profitability, HAFNIA LIMITED has a trailing twelve months EPS of kr16.95.
PE Ratio
HAFNIA LIMITED has a trailing twelve months price to earnings ratio of 4.63. Meaning, the purchaser of the share is investing kr4.63 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.78%.
More news about HAFNIA LIMITED.
3. NEOEN (NEOEN.PA)
48.5% sales growth and 3.27% return on equity
Neoen S.A., an independent renewable energy production company, engages in the development and operation of renewable energy power plants. The company operates through Solar Power, Wind Power, Storage, Farm-Down, Development and Investments, and Eliminations segments. It operates in Argentina, Australia, Canada, Ecuador, the United States, Finland, France, Ireland, Italy, Jamaica, Mexico, Mozambique, Portugal, El Salvador, Sweden, and Zambia. Neoen S.A. was incorporated in 2008 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, NEOEN has a trailing twelve months EPS of €0.94.
PE Ratio
NEOEN has a trailing twelve months price to earnings ratio of 27.91. Meaning, the purchaser of the share is investing €27.91 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.27%.
Volume
Today’s last reported volume for NEOEN is 300989 which is 88.61% above its average volume of 159578.
More news about NEOEN.
4. SPAREBANKEN VEST (SVEG.OL)
18.1% sales growth and 18.33% return on equity
Sparebanken Vest, a financial services company, provides banking and financing services in the counties of Vestland and Rogaland, Norway. The company operates through Corporate Market, Retail Market, Bulder Bank, Treasury, and Estate Agency Activities segments. It is also involved in home mortgage activities. Sparebanken Vest was founded in 1823 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN VEST has a trailing twelve months EPS of kr15.12.
PE Ratio
SPAREBANKEN VEST has a trailing twelve months price to earnings ratio of 8.43. Meaning, the purchaser of the share is investing kr8.43 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.33%.
Moving Average
SPAREBANKEN VEST’s value is under its 50-day moving average of kr132.76 and above its 200-day moving average of kr121.00.
Revenue Growth
Year-on-year quarterly revenue growth grew by 26.8%, now sitting on 6.89B for the twelve trailing months.
More news about SPAREBANKEN VEST.
5. SPAREBANK 1 SMN (MING.OL)
14.4% sales growth and 14.9% return on equity
SpareBank 1 SMN, together with its subsidiaries, provides various banking, accounting, and real estate products and services to private individuals and companies in Norway and internationally. The company offers mortgage, vehicle, green, move, consumer and other loans; refinancing; and placement, group, savings, business, group, tax deduction, currency, and deposit accounts. It also provides BSU house savings for young people; fixed interest deposits; savings and investments; cash services; and payments. In addition, the company offers car, home, personal, animal, vehicle, and travel insurance services; property buying and selling advisory services; and mobile and online banking, and various cards. Further, it offers loans for car, vehicles, and trailers, bank guarantees, business and construction loans, operating credit for agriculture, factoring, leasing, and overdrafts; various pension products; and business and personal insurance products. Additionally, the company provides documentary collection, letter of credit, forward contracts, and foreign currency account services; and accounting, HR services, taxes and duties, transactional advice, and IT solutions services. It offers money transfer, capital and investment management, advisory, interest rate and currency hedging, and investment of surplus liquidity services. SpareBank 1 SMN was founded in 1823 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, SPAREBANK 1 SMN has a trailing twelve months EPS of kr17.98.
PE Ratio
SPAREBANK 1 SMN has a trailing twelve months price to earnings ratio of 8.49. Meaning, the purchaser of the share is investing kr8.49 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.9%.
Moving Average
SPAREBANK 1 SMN’s value is below its 50-day moving average of kr155.73 and higher than its 200-day moving average of kr146.43.
More news about SPAREBANK 1 SMN.
6. MONTEA (MONT.BR)
13.3% sales growth and 11.22% return on equity
Montea NV is a public regulated real estate company under Belgian law (GVV/SIR) that specializes in logistics real estate in Belgium, the Netherlands, France, and Germany. The company is a benchmark player in this market. Montea literally offers its customers the space to grow through versatile and innovative property solutions. In this way, Montea creates value for its shareholders. As of 31/12/2023 the property portfolio represented a total surface of 1,959,242 m², spread across 95 locations. Montea NV has been listed on Euronext Brussels (MONT) and Euronext Paris (MONTP) since the end of 2006.
Earnings Per Share
As for profitability, MONTEA has a trailing twelve months EPS of €8.31.
PE Ratio
MONTEA has a trailing twelve months price to earnings ratio of 9.54. Meaning, the purchaser of the share is investing €9.54 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.22%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.1%, now sitting on 134.71M for the twelve trailing months.
Yearly Top and Bottom Value
MONTEA’s stock is valued at €79.30 at 17:20 EST, way below its 52-week high of €88.20 and way higher than its 52-week low of €61.90.
More news about MONTEA.
7. SANOFI (SAN.PA)
7.4% sales growth and 5.82% return on equity
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 5.2% and positive 0.8% for the next.
Moving Average
SANOFI’s worth is below its 50-day moving average of €97.73 and under its 200-day moving average of €91.63.
Volume
Today’s last reported volume for SANOFI is 1839940 which is 37.38% above its average volume of 1339290.
More news about SANOFI.
